Business & Healthcare Convergence: New Challenges

by archynetyscom

Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses and shapes what we all pay for care. He is also the author of the Health Care Inc. newsletter. You can reach Bob on Signal at bobjherman.09.

This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here.

I dare you to find a more entertaining health and science video series than Alex Hogan’s STATus Report. The most recent one is all about GLP-1 pills, featuring Elaine Chen. Stay til the end, when Alex highlights the latest “drug industry rap beef.” As always, you can find me here: [email protected].

A test of a corporate medicine ban

A battle in Oregon between a local physician group and a large hospital system is testing the state’s revamped ban on corporate medicine, my colleague Tara Bannow reports.

STAT+ Exclusive Story





This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

Related Posts

Leave a Comment